Baird Reiterates Outperform Rating on Merit Medical Systems, Inc. (MMSI)

Baird analyst David Rescott reiterated an Outperform rating and $96.00 price target on Merit Medical Systems, Inc. (NASDAQ: MMSI).

The analyst commented: "Following our initiation from ~2 weeks ago, we spoke with several investors and offer select feedback and thoughts below. In general, MMSI clearly appears to be an "under-the-radar" SMid cap GARP name, appealing — we think — to a more generalist crowd with (1) execution vs. the 3-year plan and (2) potential growth upside/acceleration driven by WRAPSODY as the most common points of conversation. Our $96 price target effectively rolls forward MMSI's ~4x multiple to our FY25 revenue estimates, which most agreed was a reasonable assumption."

For an analyst ratings summary and ratings history on Merit Medical Systems, Inc. click here. For more ratings news on Merit Medical Systems, Inc. click here.

Shares of Merit Medical Systems, Inc. closed at $84.39 yesterday.

You May Also Be Interested In